Archive for the ‘Testing’ Category

COVID Shot Stroke Cover-Up And A Public Message to Anthony Fauci

https://sayerji.substack.com/p/breaking-biden-white-house-covid?

BREAKING: Biden White House COVID Stroke Cover-Up Exposed

A Pattern of Institutional Deception Finally Revealed in Stunning New Email Revelations

Newly released government documents confirm that Biden White House officials directly edited CDC messaging on COVID-19 vaccine safety in January 2023 — changing the description of a stroke risk signal in elderly Americans from “moderately elevated” to “slightly elevated,” removing the words “potential risk” entirely, and instructing health officials they “don’t want to see this document again.”

All of this happened while the same administration was aggressively pushing booster uptake in the very age group affected, and while its Surgeon General was publicly accusing independent health researchers of spreading harmful disinformation for raising the exact safety questions officials were quietly suppressing internally.

This is not a hypothetical scandal. It is documented. And for those of us who lived through the coordinated destruction of our platforms, our reputations, and our livelihoods for asking these questions in public, it is a confirmation that arrives with the full weight of vindication — and the full fury of unresolved injustice.

I was one of those researchers. And this story lands differently when you have been named a public enemy for telling the truth the government was simultaneously editing into silence.  (See link for Ji’s exposé on a purposeful bureaucratic editorial operation)

https://substack.com/home/post/p-192014160

A Public Message to Anthony Fauci

Let Me Help You Remember What Went Wrong.

In what can only be described as a New York Times public image rehabilitation attempt, former NIAID Director Anthony Fauci comes across as a Pontius Pilate – his hands washed of any responsibility for his central role as a, if not the primary, driver of public health policies that nearly destroyed the United States of America.

Dr. Fauci, we remember. We ALL remember. Here is my message to help YOU remember. Let’s start with how you helped the Biden administration threaten ALL of our jobs, but the article does not mention that. It does not mention your central role in the lockdown – in fact,

you flatly deny that your actions or policies led to any school closings or factories shut down. How is it that governors across the U.S. decided “essential” and “non-essential” businesses, and you stood by and never protested?

In August 2020 you said publicly: “If someone refuses the vaccine in the general public, then there’s nothing you can do about that. You cannot force someone to take a vaccine.” Then on September 10, 2021 — the day after Biden announced the OSHA Emergency Temporary Standard covering ~80–100 million workers — you told PBS: “I myself am quite favorably impressed by that and feel strongly that that is what we should be doing.” On November 4, 2021, testifying before the Senate HELP Committee, when Sen. Romney asked directly whether mandates would save lives, you said: “We know that vaccines absolutely save lives. And we know that mandates work.”

Also on record in a Michael Specter audiobook, Summer 2021: “It’s been proven that when you make it difficult for people in their lives, they lose their ideological bullshit, and they get vaccinated. It was played back to you at the June 2024 hearing. You did not retract it.

The mandate had no testing option for federal workers or healthcare workers — it was vaccinate or lose your job. You were the Chief Medical Advisor sitting in the White House at the time. You did not object.

We all remember, also, your key role as a driver of the lockdown.

  • You sent Dr. Clifford Lane — your NIAID deputy — to China with the WHO Joint Mission in February 2020
  • Lane returned and wrote: “China has demonstrated this infection can be controlled, albeit at great cost. This is the bottom line.”
  • Lane told you directly: “From what I saw in China, we may have to go to as extreme a degree of social distancing to help bring our outbreak under control”
  • You testified he had “every reason to believe” Lane’s evaluation
  • You then admitted: social distancing “even by somewhat difficult means” involving “essentially the entire community” was possible in the U.S.

Your methodological problems:

  1. Lane visited after China had already locked down — he could only observe what was happening, not whether the lockdown caused the decline
  2. Chinese data was demonstrably unreliable — WHO had tailored confidentiality forms “to China’s terms” (FOIA-obtained emails, Judicial Watch, March 2021) and a January 2020 WHO epidemiological analysis was marked “strictly confidential”
  3. The WHO-China Joint Mission report itself was controlled: all activities were “arranged by the Chinese Government’s National Health Commission” (per a Feb. 15, 2020 internal WHO email)

(See link for Weiler’s chronology all things fraudulently Fauci)

______________

**Comment**

It’s beyond time for vindication of those who were right all along, and accountability for those who pushed unscientific, fraudulent, and dangerous COVID measures that were ineffective and even deadly.

For more:

Lyme Disease, Tests & Treatment: A Review of the Controversy on the Effectiveness of Biological Tests & Proof of the Existence of a Chronic Form

https://www.fortunejournals.com/articles/lyme-disease-tests-and-treatment-a-review-of-the-controversy-on-the-ineffectiveness-of-biological-tests-and-proof-of-the-existence.

Lyme Disease, Tests and Treatment: A Review of The Controversy on The Ineffectiveness of Biological Tests and Proof of The Existence of A Chronic Form

Alexis Lacout*, 1, Christian Perronne2

1Centre de diagnostic, ELSAN, Centre médico –chirurgical, 83 avenue Charles de Gaulle, Aurillac, France

2Infectious and tropical diseases, Paris, France

*Corresponding author: Alexis Lacout, Centre de diagnostic, ELSAN, Centre médico –chirurgical, 83 avenue Charles de Gaulle, Aurillac, France

Received: 04 December 2024; Accepted: 09 December 2024; Published: 27 December 2024

Article Information

Citation: Alexis Lacout, Christian Perronne. Lyme Disease, Tests and Treatment: A Review of The Controversy on The Ineffectiveness of Biological Tests and Proof of The Existence of A Chronic Form. Archives of Microbiology and Immunology. 8 (2024): 543-561.

DOI: 10.26502/ami.936500203

View / Download PdfShare at Facebook

Abstract

Lyme disease is caused by infection with the bacterium Borrelia burgdorferi. Other species of Borrelia have been discovered and cause similar diseases. The first described species, Borrelia burgdorferi sensu stricto, was isolated in the United States. Lyme disease is a great imitator that can resemble many illnesses, including autoimmune diseases. ELISA and Western Blot diagnostic tests, which are supposed to have a sensitivity of almost 100%, are in fact often negative in many patients with genuine Lyme disease. These tests are poorly calibrated, of mediocre quality, with an arbitrarily defined threshold for antibody positivity, so that no more than 50% of patients with a positive test are ever found. Controversy surrounds the existence of the chronic form. However, chronicity is observed in many patients, and the mechanisms of Borrelia persistence are well documented in the literature. Recently, in 2018, the Haute Autorité de Santé (French National Authority for Health) defined SPPT (Syndrome Persistant Polymorphe Après-Piqure de Tique), enables empirical antibiotic treatment even in the absence of erythema migrans and with negative Lyme serology. Lyme disease is frequently associated with a number of other infections known as co-infections, whether parasitic, bacterial or viral. Treatment must be effective against Borrelia and other co-infections. A long course of antibiotics lasting several weeks or months may be required. Relapses are frequent when treatment is stopped, due to Borrelia’s persistence mechanisms, and require rapid reintroduction of previously effective treatments. Denial of the scientific realities described in this article has resulted in hundreds of thousands of patients wandering around with untreated, disabling symptoms, despite the fact that appropriate, low-cost anti-infective treatment enables remission in many cases.

For more:

Understanding Tick-Borne Disease Testing in 2026

http://

Understanding Tick-Borne Disease Testing in 2026

IGeneX Inc.

Tick-borne diseases continue to be among the most complex and misunderstood conditions in modern medicine. As the landscape of diagnostics evolves rapidly, clinicians and healthcare professionals face increasing challenges—and opportunities—in accurately identifying infections, co-infections, and immune responses that directly impact patient outcomes.
 
In this forward-looking IGeneX webinar, learn how advances in laboratory science, expanded pathogen detection, and improved testing methodologies are reshaping the way tick-borne diseases are evaluated and managed. Attendees will gain a clear, practical understanding of how modern diagnostics are addressing longstanding limitations in sensitivity, specificity, and clinical interpretation.
 
This session will examine:
  • The current and emerging challenges in tick-borne disease testing, including evolving pathogens, regional variability, and complex clinical presentations
  • Advances in diagnostic technologies, such as enhanced immunoblots, cellular immune assays, and expanded multi-species detection
  • How testing has evolved beyond single-pathogen models to better identify co-infections and immune dysfunction
  • The role of clinical context in test interpretation, and how modern diagnostics support more informed decision-making
  • What to expect in 2026 and beyond, including trends in test development, regulatory considerations, and data-driven diagnostics

Designed for physicians, nurse practitioners, physician assistants, and other healthcare professionals involved in diagnosing and managing tick-borne diseases, this webinar bridges the gap between laboratory innovation and real-world clinical practice. Whether you are new to advanced tick-borne testing or looking to stay ahead of emerging diagnostic trends, this session will provide actionable insights to support more confident testing strategies and improved patient care.

For more:

 

Scientists Issue Warning Over Rise to Ticks Carrying Multiple Diseases

https://www.newsweek.com/us-northeast-warned-rise-multiple-disease-bearing-ticks

Scientists Issue Warning Over Rise of Ticks Carrying Multiple Diseases

By 

Ticks capable of carrying and transmitting more than one potentially fatal disease at the same time are becoming increasingly common in the northeastern U.S., according to a new long-term analysis that raises fresh public health concerns for the region.

The research found that a growing share of blacklegged ticks—also known as deer ticks—are infected with multiple disease-causing pathogens. The study was led by Cary Institute of Ecosystem Studies disease ecologist Shannon LaDeau and conducted in partnership with the SUNY Center for Vector-Borne Diseases at Upstate Medical University.

The findings come from nearly a decade of tick surveillance and point to a more complex and potentially dangerous tick-borne disease landscape, particularly because different infections require different treatments.

“Healthcare workers should be on the lookout for rising co-infection risks,” LaDeau said in a statement. “And for people spending time outdoors in the Northeast, as a general rule, if the ground is not freezing, it’s a good idea to take precautions to avoid tick bites. Prevention is key.”  (See link for article)

_____________

Findings:

  • 1 in10 nymphs tested positive for at least two pathogens: Borrelia burgdorferi (19.3%) and Babesia microti (21%) were the most common followed by Anaplasma phagocytophilum (5.8%) and Borrelia miyamotoi (2%)
  • by the end of the study period 11% of sampled ticks had coinfections
  • coinfection rate has been increasing over time
  • 38% of nymphs were capable of transmitting at least one disease to humans

For more:

 

Podcast: Why Lyme Disease Happens to Some People and Not Others

https://www.lymedisease.org/why-lyme-happens-some-not-others/  Go here for video

PODCAST: Why Lyme disease happens to some people and not others

By Fred Diamond

One of the most common questions I hear from Lyme survivors is simple but deeply loaded: “Why did this happen to me? Why did I get Lyme when others didn’t?”

If you’ve ever asked yourself, “Why me?” know that you’re not alone.

Thousands of Lyme survivors have pondered that same question. They were healthy. They were hiking. They were gardening. They were kayaking. They were simply living their lives. And then something changed.

On this week’s Love, Hope, Lyme podcast, Dr. Jennifer Miller of Galaxy Diagnostics, a scientist who has spent her career studying the Lyme bacterium, Borrelia burgdorferi, discusses why Lyme happens and why its effect may differ from person to person.

Her explanation reveals just how complex, and insidiously strategic, this organism truly is.

It starts in the wild

Lyme disease is what scientists call a vector-borne infection. In simple terms, that means it is transmitted by a vector and in this case, ticks.

But ticks are not born infected.

“The tick has to pick it up from a host that’s already infected,” Dr. Miller explains. “The larval tick will feed on an infected animal… and acquire the infection.”

That infected animal is usually a small mammal such as a mouse, chipmunk, or squirrel. These animals act as reservoir hosts. They carry the bacteria without becoming visibly sick.

After feeding, the tick molts into a nymph which is the stage most responsible for transmitting Lyme to humans. Nymphs are tiny, often no bigger than a poppy seed, and difficult to detect.

Many people assume deer are the main source of Lyme. Dr. Miller clarifies the nuance.

“Deer can have Lyme disease, but people aren’t going to get it from a deer.”

Deer play a role in the tick life cycle, but they are not the direct cause of human infection. The real issue is ecological.

“Because we have all these reservoir hosts, it’s a big part of the problem as to why Lyme disease incidence is increasing and why it’s spreading,” she says. “As humans, we occupy and consume more and more space… we’re encroaching on the territory of the deer, and with that, very unfortunately, comes Lyme disease.”

In other words, Lyme is not random. It is the byproduct of an expanding interface between humans and the natural infection cycle.

Borrelia is not an ordinary bacterium

Lyme disease is caused by a bacterium, not a virus, but it behaves unlike most bacteria.

Borrelia belongs to a family called spirochetes. It has a corkscrew shape that gives it unusual mobility.

“Borrelia will literally outrun the immune system,” Dr. Miller says. “Because it’s a corkscrew, it literally will burrow into the tissues.”

That corkscrew motion allows it to penetrate deeply into connective tissue, joints, and even cross protective barriers like the blood-brain barrier.

Even more concerning, Borrelia is highly adaptive.

“It literally will coat itself with host proteins. That allows it to evade immune detection.”

Camouflage

In essence, the bacterium can camouflage itself. It changes the proteins on its surface depending on whether it is inside a tick or inside a human. Once inside the body, it can alter its “coat” again to hide from immune surveillance.

Unlike some bacteria that cause disease by releasing toxins, Borrelia’s damage often comes indirectly.

“They’re not making toxins or poisons like other bacteria,” Dr. Miller explains. “But a lot of what happens with Borrelia is triggered by the immune system.”

The medical literature uses the phrase immune dysregulation to describe this phenomenon.

“Borrelia really interferes with the immune system,” she says.

In some individuals, the immune response becomes excessive and inflammatory, leading to joint damage, neurological symptoms, and widespread pain. In others, the immune response is blunted or misdirected, allowing the bacterium to persist quietly.

Why do some people get so sick while others don’t?

This may be the most painful question Lyme survivors ask.

“That’s still the biggest question that we need to answer,” Dr. Miller says candidly. “What I’ll tell you quite openly is that we don’t have all the answers.”

But there are clues.

Different strains of Borrelia produce slightly different surface proteins.

“Depending on which version of those proteins they’re making, some of those versions disagree with certain humans more than others.”

Some strains provoke a strong immune reaction. Others may slip past immune detection more easily.

Borrelia also actively interferes with antibody production.

“Borrelia will interfere with the timing of the antibody response. It interferes with the strength of the antibody response,” she explains. “It will trick them and confuse them so that they don’t produce antibodies in the right timeframe or of the right strength.”

This has enormous implications. If the immune system does not respond in a predictable way, both symptoms and laboratory tests become harder to interpret.

Host factors matter too. Genetics, previous infections such as Epstein-Barr virus, co-infections, mold exposure, chronic stress, and environmental burdens may all influence how a person responds.

There is likely no single reason why one person clears infection and another develops chronic symptoms. It is a complex interaction between pathogen and host.

The complication of co-infections

Lyme rarely travels alone.

“The number of different pathogens that were in the tick was far more than anybody would’ve thought… easily dozens,” Dr. Miller notes.

Ticks may carry Borrelia along with Babesia (a parasite similar in some ways to malaria), Bartonella (a different type of bacteria), Anaplasma, Ehrlichia, and even viral pathogens.

“You really have a lot of diversity of pathogens with these co-infections. That’s part of why they can be so very difficult to treat.”

A tick can acquire pathogens from one animal, survive the molt, then feed on another animal and acquire additional organisms. Birds, which can transport infected ticks across geographic regions, add another layer of complexity.

This microbial diversity means that two people bitten by ticks in different environments may experience very different symptom patterns.

Why testing fails so often

Few topics frustrate Lyme patients more than testing.

The standard two-tier antibody testing protocol has been in use for more than three decades. It measures antibodies but not the bacteria itself.

“The current tests are detecting that antibody response, and that can be very tricky,” Dr. Miller explains.

Antibodies only tell you that your immune system has seen the pathogen at some point. They do not reliably indicate active infection. And because Borrelia interferes with antibody production, some people never produce a strong enough response to meet diagnostic thresholds.

“Not everybody even generates an antibody response to Borrelia, one that’s strong enough or in line with what our out-of-date tests measure.”

False negatives can occur. Partial antibody bands may appear but not meet reporting criteria. Cross-reactivity with other infections can create additional confusion.

Adding to the challenge, Borrelia does not remain in high concentrations in the bloodstream.

“They don’t hide out at large numbers in the blood. There’s just not a lot of Borrelia in the blood.”

After transmission through the skin, the bacteria migrate into tissues. Blood-based detection becomes inherently difficult. This is why some researchers are working to develop direct detection methods, including antigen testing strategies.

“Borrelia are unique,” Dr. Miller explains. “When Borrelia shed their outer proteins it just gets released into the environment.”

Unlike many bacteria, Borrelia sheds structural components that may be detectable in other bodily fluids, offering a potential alternative to antibody-based testing.

A final word to patients

Lyme disease is biologically complex. It is ecologically driven. It is immunologically disruptive, and it does not behave like many other infections.

The science is still evolving. Researchers do not have all the answers.

But one thing is clear.

“If you think you have symptoms of Lyme disease and you haven’t seen a tick and you don’t have that bull’s-eye rash, please don’t assume that you don’t have Lyme disease,” Dr. Miller urges. “Go and get checked out.”

For survivors searching for understanding, the question why did this happen may never have a simple answer. But understanding biology, ticks, the bacterium, the immune system, and the co-infections can bring clarity.

And the more we understand that organism, the closer we move toward better diagnostics, better treatments, and better outcomes for every Lyme survivor.

Visit the Galaxy Diagnostics website to learn more about Lyme disease testing.

Click here to listen to all episodes of the Love, Hope, Lyme Podcast or on YouTube.